Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo
Language English Country Netherlands Media print
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Afibrinogenemia genetics MeSH
- Point Mutation * MeSH
- Adult MeSH
- Fibrinogen genetics MeSH
- Fibrinogens, Abnormal genetics MeSH
- Heterozygote MeSH
- Middle Aged MeSH
- Humans MeSH
- Hemorheology MeSH
- Thrombosis etiology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- BBeta fibrinogen MeSH Browser
- fibrinogen Rokycany MeSH Browser
- fibrinogen Znojmo MeSH Browser
- Fibrinogen MeSH
- Fibrinogens, Abnormal MeSH
Hereditary dysfibrinogenemia is a rare disorder wherein an inherited abnormality in fibrinogen structure may result in defective fibrin function and/or structure. Congenital hypofibrinogenemia is a rare autosomal bleeding disorder, either recessive or dominant, characterized by a low fibrinogen plasma level. A 28-year-old asymptomatic woman (fibrinogen Rokycany) and a 54-year-old man with thrombosis and pulmonary embolism (fibrinogen Znojmo) were investigated for a suspected fibrinogen mutation after abnormal coagulation tests results were obtained. DNA sequencing showed the heterozygous point mutation Bβ Asn351Lys in fibrinogen Rokycany and the heterozygous point mutation Bβ Arg237Ser in fibrinogen Znojmo, respectively. The kinetics of fibrinopeptide release was found to be normal in both cases. Fibrinolysis was impaired in the Znojmo variant. The average fibril diameters of Znojmo fibrin was slightly increased, but not differing significantly from normal; formed by less fibrils with abrupt fibril terminations. Rheological studies revealed a softer clot. Rokycany fibrin was formed by significantly narrower fibrils than normal fibrin; and the clot was denser than the control clot. Rheological studies revealed a stiffer clot. Impaired fibrinolysis and abnormal clot morphology may be the cause of thrombotic episodes in the patient with Znojmo mutation. New cases of hypofibrinogenemia and dysfibrinogenemia, found by routine coagulation testing, were genetically identified as a novel fibrinogen variants Bβ Asn351Lys (fibrinogen Rokycany) and Bβ Arg237Ser (fibrinogen Znojmo), respectively.
See more in PubMed
Acta Haematol. 2008;120(2):75-81 PubMed
Eur J Haematol. 2007 May;78(5):410-6 PubMed
J Thromb Haemost. 2009 Feb;7(2):355-9 PubMed
Biochem Biophys Res Commun. 2009 Jan 16;378(3):662-7 PubMed
Biochim Biophys Acta. 2003 Feb 21;1645(2):146-51 PubMed
Nucleic Acids Res. 1988 Feb 11;16(3):1215 PubMed
Thromb Haemost. 2001 Mar;85(3):450-3 PubMed
J Thromb Haemost. 2005 Oct;3(10):2347-9 PubMed
Blood. 2009 Aug 27;114(9):1929-36 PubMed
J Thromb Haemost. 2006 May;4(5):1134-6 PubMed
Blood. 2000 Feb 15;95(4):1336-41 PubMed
Thromb Haemost. 2009 Sep;102(3):479-86 PubMed
Haemophilia. 2008 May;14(3):630-3 PubMed
J Clin Invest. 1995 Dec;96(6):2854-8 PubMed
Blood. 2003 Dec 15;102(13):4413-5 PubMed
Thromb Res. 2007;121(1):75-84 PubMed
J Biol Chem. 1996 Nov 1;271(44):27942-7 PubMed
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1086-9 PubMed
J Biol Chem. 1993 Apr 25;268(12):8919-26 PubMed
J Mol Biol. 1989 Apr 20;206(4):759-77 PubMed
Nature. 1997 Oct 2;389(6650):455-62 PubMed
J Biol Chem. 1996 Oct 4;271(40):24544-50 PubMed
Biochim Biophys Acta. 1968 Jun 26;160(2):280-3 PubMed
Haematologica. 2006 May;91(5):628-33 PubMed
Glycobiology. 2005 Feb;15(2):153-64 PubMed
Liver. 1992 Dec;12(6):357-62 PubMed
Ann N Y Acad Sci. 2001;936:480-95 PubMed
Ann N Y Acad Sci. 2001;936:89-90 PubMed
J Thromb Haemost. 2003 Jun;1(6):1251-7 PubMed
Structure. 1997 Jan 15;5(1):125-38 PubMed
